Global Antimicrobial Therapeutics Market Report and Forecast 2025-2034

Antimicrobial Therapeutics: Introduction

Antimicrobial therapeutics involve a set of treatments for infections or diseases caused by bacteria, fungus, viruses, or parasites. They work by either killing the microorganisms or inhibiting its growth. It includes a range of drugs such as antibiotics, antivirals, antifungals, and antiparasitic. The development and application of antimicrobial medications can be considered crucial in treating infectious diseases, preventing the spread of infections, and saving lives.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Antimicrobial Therapeutics Market Analysis

Antimicrobial therapeutics include treatments against several microorganisms such as bacteria, viruses, fungi, and parasites. The antimicrobial therapeutics market growth is fuelled by the development and approval of drugs. In March 2023, the FDA approved Cidara Therapeutics Inc's drug, rezafungin (branded as Rezzayo), to treat a group of severe fungal infections, commonly faced by hospitalized patients.

In November 2023, the FDA also approved a new beta-lactam/beta-lactamase inhibitor antibiotic, sulbactam-durlobactam for patients with carbapenem-resistant Acinetobacter infection. This group of bacteria has been responsible for causing blood infections, pneumonia and urinary tract infections. Apart from pharmacological approaches, researchers have been working towards developing combination therapies to bring effective and rapid solutions for the patients.

Antimicrobial resistance is turning out to be a global health concern and is expected to surpass 10 million  deaths globally by 2050. As a result, the antimicrobial therapeutics market value is driven by strong emphasis on battling anti-microbial resistance. To combat the rising burden, companies like Glox Therapeutics (a Scottish company) are working towards developing precision antibiotics with the help of protein bacteriocins that exhibit targeted specificity for gram negative pathogens. With the ongoing developments and extensive research, the market is projected to grow significantly in the forecast period.

Global Antimicrobial Therapeutics Market Segmentation

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Antimicrobial Therapeutics Market Overview

The United States, with a prominent research and development infrastructure and key healthcare companies, has led the market antimicrobial therapeutics market share in recent years. This trend is expected to continue with rising privatization of the medical ecosystem. The acquisition of smaller research companies by pharmaceutical giants is fostering market growth. In addition, the establishment of new and high-end research centers in the region is also expected to improve the quality and frequency of drug development and approvals in the region.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

With several influential government programs, the European region is another key player in the market. A program called PACE (Pathways to Antimicrobial Clinical Efficacy) set up under the collaboration of Innovate UK and LifeArc & Medicines Discovery Catapult is offering a GBP 10 million grant funding for the early phase drug discovery and diagnostic projects. Such initiatives are expected to add to the market growth significantly.

The Asia Pacific region is also projected to witness expediated antimicrobial therapeutics market growth in the forecast period, owing to rising investments with an increased emphasis on improving the medical infrastructure. The region is experiencing a rising number of drug approvals which are expected to impact the market positively in upcoming years.

Global Antimicrobial Therapeutics Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• F. Hoffmann-La Roche Ltd.

• Mylan N.V.

• Sanofi

• Pfizer Inc.

• GlaxoSmithKline plc (GSK)

• Novartis AG

• Bayer AG

• Merck & Co., Inc.

• Sun Pharmaceutical Industries Ltd.

• Aurobindo Pharma

• Lupin

• Fresenius Kabi AG

• Akorn Incorporated

• Teva Pharmaceutical Industries Ltd.

• AstraZeneca plc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.